Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 September 2022 | Story Jóhann Thormählen | Photo iStock
Cervical cancer awareness ribbon
Cervical Cancer Awareness Month is observed in September in South Africa to encourage women to go for screening to prevent it.

Cervical cancer is the second most common cancer among women in South Africa, and many die from it each year – but it can be prevented.

According to Dr Arina Meyer, medical practitioner in Kovsie Health at the University of the Free State, this is one of the reasons why it is important to be informed, take precautions, and raise awareness about the disease.

Cervical Cancer Awareness Month is observed in September in South Africa with the aim of encouraging women to go for screening to prevent it.

Although medical statistics paint a bleak picture, Meyer says there is hope. “It is important to know that cervical cancer can be prevented. And when it is diagnosed early, it can be treated.”

Statistics and causes

According to her, figures show the occurrence of cervical cancer to be between 22,8 and 27 per 100 000 women in South Africa. 

“More than 5 700 new cases are reported each year, as well as more than 3 000 deaths. Cervical cancer is the second most common cancer – after skin cancer – in South Africa.”

Meyer says when one look at these numbers, it is important to commemorate Cervical Cancer Awareness Month, as women need to be informed about their annual check-up, possible symptoms, and signs of the cancer.

Most cervical cancers are caused by the human papillomavirus (HPV), which is transmitted through sexual contact. Therefore, the HPV is seen as a sexually transmitted disease.

“There are different types of HPV. Some cause cervical cancer and other genital warts. One can develop one or both conditions, depending on the type of virus you have,” says Meyer.

Prevention and reducing the risk

According to her, preventative action is the best method. Going for a cervical screening every year when you become sexually active, such as a Pap smear or Pap test, will help in the early detection and removal of abnormal cells.

There is also a vaccine for protection against HPV, which is available from the age of nine. Meyer says there are two vaccines in South Africa.

“By getting the vaccine early, before any sexual activity, the spread of HPV – and therefore cervical cancer – can be prevented. Up to 90% of cancers can be prevented.
“Unfortunately, if someone has already been infected by the HPV, it cannot be treated by the vaccine.”

The UFS medical practitioner says the best ways to reduce the risk of cervical cancer are to go for an annual Pap smear, a follow-up after an abnormal test result, the vaccine, safe sex, and to stop smoking.

News Archive

Office of Technology Transfer receives multimillion rand grant
2016-01-15


The university’s Office of Technology Transfer (OTT) received multimillion rand funding for the office to provide much needed support for academia to have their ideas and research effectively turned into business ventures.

This grant of over R4 million by the National Intellectual Property Management Office (NIPMO), under the auspices of the Department of Science and Technology, will help the OTT to provide an enabling environment for cooperation between academia and industry to transform innovation emanating from research and development at the UFS into business ventures.

“Research and innovation plays a prominent role in the financial sustainability of an institution, in that it has the capacity to be the largest generator of third-steam income,” says Gerhard Verhoef, Director: Contracts and Innovation at the Directorate Research Development at the UFS.

“The OTT is a very new office and this grant, provided over three years, will help us fulfil our mandate.”

NIPMO aims to ensure that recipients of funding from a government funding agency assess, record and report on the benefit to society of IP emanating from publicly-financed research and development. Recipients must protect IP emanating from publicly-financed research and development from appropriation and ensure that it is available to the people of South Africa. A recipient must identify commercialisation opportunities for IP emanating from publicly-financed research and development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept